Boardroom Alpha
Meeting calendar
ADNT · Annual meeting · Tuesday, March 10, 2026

Adient PLC

8 nominees · 5 ballot items.

Election of eight directors; ratification of PricewaterhouseCoopers LLP as auditor and authorization to set their remuneration; advisory approval of named executive officer compensation; renewal of Board authority to issue shares under Irish law; renewal of Board authority to opt-out of statutory preemption rights under Irish law (conditional on Proposal 4); and receipt and consideration of Adient’s Irish Statutory Accounts.

Market cap
$1.6B
1Y TSR
-10.9%
Board grade
C-
Record date
Jan 14, 2026
Filing
DEF 14A
Meeting concluded · Mar 10, 2026

Follow how the vote landed and what changed on Adient PLC’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot5

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect eight directors to serve until the 2027 Annual General Meeting.

  2. 2

    Ratification of Independent Auditor and Authorization to Set Auditors’ Remuneration

    ManagementBoard: FOR

    Ratify appointment of PricewaterhouseCoopers LLP as independent auditor for fiscal year 2026 and authorize the Board, acting through the Audit Committee, to set auditors’ remuneration.

    More detail

    The proposal asks shareholders to ratify PwC as Adient’s independent auditor for fiscal year 2026 and to authorize the Board (via the Audit Committee) to set the auditors’ fees. Management seeks shareholder ratification as a standard corporate practice and to confirm the Audit Committee’s selection; the proxy discloses PwC’s engagement and prior audit of fiscal year 2025. Ratification is non-binding and routine; if not ratified the Audit Committee would consider another auditor, although it retains discretion to change auditors regardless of the vote. The board recommends a FOR vote, emphasizing PwC’s role, independence assessments by the Audit Committee, and continuity benefits (familiarity with the company’s accounting and risks). The resolution includes verbatim text authorizing the ratification and fee-setting. This is a routine audit-related matter and carries low governance risk, but a negative vote could signal shareholder concern about audit quality or independence and prompt the Audit Committee to review the relationship, fees, and potential rotation plans.

  3. 3

    Advisory Vote on Named Executive Officer Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding advisory vote to approve the compensation of named executive officers as disclosed in the proxy statement.

    More detail

    The advisory proposal requests shareholder approval of the overall compensation program for Adient’s named executive officers as described in the CD&A and compensation tables. Management frames its program around pay-for-performance, long-term alignment via RSUs/PSUs, and retention, noting specific metrics (Adjusted EBITDA, Free Cash Flow, Return on Sales, cumulative FCF, relative TSR) and increased percent of pay at risk. The board recommends a FOR vote, highlighting peer benchmarking, use of independent consultants (Willis Towers Watson), clawback policies, ownership guidelines, and adjustments made to incentive outcomes considering restructuring costs and tariffs. As advisory, it’s non-binding but influences the Human Capital and Compensation Committee; a negative vote could trigger program redesign or heightened shareholder engagement. This item is governance-sensitive, linking pay outcomes to TSR and other financial measures, with the board arguing that compensation is aligned to shareholder interests while also maintaining retention and market competitiveness.

  4. 4

    Authorization of the Board to Issue Shares Under Irish Law

    ManagementBoard: FOR

    Renew the Board’s authority, under Irish law, to allot and issue ordinary shares up to approximately 20% of issued share capital for 18 months.

  5. 5

    Authorization of the Board to Opt-Out of Statutory Preemption Rights Under Irish Law

    ManagementBoard: FOR

    Renew authority for the Board to issue shares for cash without first offering them pro rata to existing shareholders (opt out of preemption rights), up to ~20% of issued share capital, conditional on Proposal 4.

Director elections

Nominees on the ballot8

Independent
Tenure on this board
10.5 yrs
Also a director at
Phillips 66 (PSX)Bio-techne Corp (TECH)
Independent
Tenure on this board
10.5 yrs
Also a director at
Marriott International Inc (MAR)
Ownership

Top institutional holders10

Latest 13F quarter
1BlackRock, Inc.10.7%8,375,719$169M
2DIMENSIONAL FUND ADVISORS LP5.4%4,227,533$85M
3PZENA INVESTMENT MANAGEMENT LLC4.6%3,635,297$73M
4STATE STREET CORP4.0%3,139,267$63M
5VANGUARD PORTFOLIO MANAGEMENT LLC3.9%3,033,094$61M
6BlackRock, Inc.3.6%2,828,826$57M
7HOTCHKIS WILEY CAPITAL MANAGEMENT LLC2.9%2,312,700$47M
8Woodline Partners LP2.9%2,312,005$47M
9ARROWSTREET CAPITAL, LIMITED PARTNERSHIP2.9%2,293,353$46M
10HITE Hedge Asset Management LLC2.3%1,796,652$36M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Adient PLC 2026 annual meeting?
Adient PLC (ADNT) holds its 2026 annual shareholder meeting on Tuesday, March 10, 2026.
What is the record date for the Adient PLC 2026 meeting?
The record date for the Adient PLC 2026 meeting is Wednesday, January 14, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Adient PLC's 2026 meeting?
The board is presenting 8 director nominees at the Adient PLC 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Adient PLC 2026 meeting?
Shareholders will vote on 5 proposals at the Adient PLC 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer